Clinical Trial Update: Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the combination of Velcade (bortezomib) and temozolomide in patients with brain tumors or other solid tumors that had not responded to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Cancer
• Central Nervous System Tumors
• Lymphoma
• Solid Tumors

Drugs mentioned

• Temodar (Temozolomide)
• Velcade (bortezomib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Brain and Central Nervous System Tumors, Lymphoma | Phase 1 | Status: COMPLETED